These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
79 related items for PubMed ID: 9865748
1. Fas-mediated apoptosis in human prostatic carcinoma cell lines occurs via activation of caspase-8 and caspase-7. Rokhlin OW, Glover RA, Cohen MB. Cancer Res; 1998 Dec 15; 58(24):5870-5. PubMed ID: 9865748 [Abstract] [Full Text] [Related]
2. Cytochrome c is involved in Fas-mediated apoptosis of prostatic carcinoma cell lines. Gewies A, Rokhlin OW, Cohen MB. Cancer Res; 2000 Apr 15; 60(8):2163-8. PubMed ID: 10786680 [Abstract] [Full Text] [Related]
3. Fas-mediated apoptosis in human prostatic carcinoma cell lines. Rokhlin OW, Bishop GA, Hostager BS, Waldschmidt TJ, Sidorenko SP, Pavloff N, Kiefer MC, Umansky SR, Glover RA, Cohen MB. Cancer Res; 1997 May 01; 57(9):1758-68. PubMed ID: 9135020 [Abstract] [Full Text] [Related]
4. Dominant nature of the resistance to Fas- and tumor necrosis factor-alpha-mediated apoptosis in human prostatic carcinoma cell lines. Rokhlin OW, Hostager BS, Bishop GA, Sidorenko SP, Glover RA, Gudkov AV, Cohen MB. Cancer Res; 1997 Sep 15; 57(18):3941-3. PubMed ID: 9307276 [Abstract] [Full Text] [Related]
5. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand. Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I. Cancer Res; 2000 Aug 01; 60(15):4122-9. PubMed ID: 10945619 [Abstract] [Full Text] [Related]
6. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling. Perchellet EM, Wang Y, Weber RL, Sperfslage BJ, Lou K, Crossland J, Hua DH, Perchellet JP. Biochem Pharmacol; 2004 Feb 01; 67(3):523-37. PubMed ID: 15037204 [Abstract] [Full Text] [Related]
7. Contribution of death receptor and mitochondrial pathways to Fas-mediated apoptosis in the prostatic carcinoma cell line PC3. Guseva NV, Taghiyev AF, Rokhlin OW, Cohen MB. Prostate; 2002 Jun 01; 51(4):231-40. PubMed ID: 11987151 [Abstract] [Full Text] [Related]
8. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid. Hougardy BM, van der Zee AG, van den Heuvel FA, Timmer T, de Vries EG, de Jong S. Gynecol Oncol; 2005 May 01; 97(2):353-64. PubMed ID: 15863130 [Abstract] [Full Text] [Related]
9. Caspase-1 is not involved in CD95/Fas-induced apoptosis in Jurkat T cells. Chow SC, Slee EA, MacFarlane M, Cohen GM. Exp Cell Res; 1999 Feb 01; 246(2):491-500. PubMed ID: 9925765 [Abstract] [Full Text] [Related]
10. Differential regulation of Fas-mediated apoptosis of rheumatoid synoviocytes by tumor necrosis factor alpha and basic fibroblast growth factor is associated with the expression of apoptosis-related molecules. Kobayashi T, Okamoto K, Kobata T, Hasunuma T, Kato T, Hamada H, Nishioka K. Arthritis Rheum; 2000 May 01; 43(5):1106-14. PubMed ID: 10817565 [Abstract] [Full Text] [Related]
11. Fas- and interferon gamma-induced apoptosis in Chang conjunctival cells: further investigations. De Saint Jean M, Debbasch C, Rahmani M, Brignole F, Feldmann G, Warnet JM, Baudouin C. Invest Ophthalmol Vis Sci; 2000 Aug 01; 41(9):2531-43. PubMed ID: 10937564 [Abstract] [Full Text] [Related]
12. Tumor necrosis factor alpha regulation of the FAS-mediated apoptosis-signaling pathway in synovial cells. Kobayashi T, Okamoto K, Kobata T, Hasunuma T, Sumida T, Nishioka K. Arthritis Rheum; 1999 Mar 01; 42(3):519-26. PubMed ID: 10088775 [Abstract] [Full Text] [Related]
13. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Fulda S, Meyer E, Debatin KM. Cancer Res; 2000 Jul 15; 60(14):3947-56. PubMed ID: 10919673 [Abstract] [Full Text] [Related]
14. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer. Mueller T, Voigt W, Simon H, Fruehauf A, Bulankin A, Grothey A, Schmoll HJ. Cancer Res; 2003 Jan 15; 63(2):513-21. PubMed ID: 12543810 [Abstract] [Full Text] [Related]
15. A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells. Juang SH, Pan WY, Kuo CC, Liou JP, Hung YM, Chen LT, Hsieh HP, Chang JY. Biochem Pharmacol; 2004 Jul 15; 68(2):293-303. PubMed ID: 15194001 [Abstract] [Full Text] [Related]
16. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma. Mezzanzanica D, Balladore E, Turatti F, Luison E, Alberti P, Bagnoli M, Figini M, Mazzoni A, Raspagliesi F, Oggionni M, Pilotti S, Canevari S. Clin Cancer Res; 2004 Aug 01; 10(15):5202-14. PubMed ID: 15297424 [Abstract] [Full Text] [Related]
17. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells. Sylvester PW, Shah S. Asia Pac J Clin Nutr; 2005 Aug 01; 14(4):366-73. PubMed ID: 16326643 [Abstract] [Full Text] [Related]
18. The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathway. Liu B, Fan Z. Oncogene; 2001 Jun 21; 20(28):3726-34. PubMed ID: 11439335 [Abstract] [Full Text] [Related]
19. Fas antigen modulates ultraviolet B-induced apoptosis of SVHK cells: sequential activation of caspases 8, 3, and 1 in the apoptotic process. Takahashi H, Nakamura S, Asano K, Kinouchi M, Ishida-Yamamoto A, Iizuka H. Exp Cell Res; 1999 Jun 15; 249(2):291-8. PubMed ID: 10366428 [Abstract] [Full Text] [Related]
20. Mechanism of Fas-mediated cell death and its enhancement by TNF-alpha in human salivary gland adenocarcinoma cell line HSG. Chosa N, Kyakumoto S, Kito N, Kamo M, Sato N. Eur J Oral Sci; 2004 Aug 15; 112(4):338-46. PubMed ID: 15279653 [Abstract] [Full Text] [Related] Page: [Next] [New Search]